アルギナーゼ阻害剤
Arginase, an Mn2+ metalloenzyme, catalyzes the hydrolysis of L-arginine to yield L-ornithine and urea in ureotelic animals. Based on their distribution, two isoforms of arginase have been described. Type I arginase, a cytosolic enzyme, is found in the hepatic tissue and besides participating in the urea cycle, it also plays a significant role in limiting the supply of arginine for nitric oxide (•NO) synthesis. Type II arginase is a mitochondrial enzyme found in extrahepatic tissues, and is involved in the regulation of extra-urea cycle arginine metabolism and in the down-regulation of NO synthesis. Due to the reciprocal regulation between arginase and nitric oxide synthase, arginase inhibitors are considered to have therapeutic potential in treating NO-dependent smooth muscle disorders, such as erectile dysfunctions and polyamine induced bronchial constriction.
References:
Colleluori, D.M., and Ash, D.E. 2001. Biochemistry 40, 9356.
Ozaki, M., et al. 1999. J. Biochem. 125, 586.
Salimuddin et al. 1999. Am J. Physiol. Endocrinol. Metab. 277, E110.
Morris, S.M. Jr., et al. 1998. Am J. Physiol. Endocrinol. Metab. 275, E740.
